S L Gorbach
Overview
Explore the profile of S L Gorbach including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
333
Citations
6698
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Snydman D, Jacobus N, McDermott L, Golan Y, Goldstein E, Harrell L, et al.
Anaerobe
. 2011 Jun;
17(4):147-51.
PMID: 21664469
The susceptibility trends for the species of the Bacteroides fragilis group against various antibiotics were determined using data from 4 years [2006-2009] on 1957 isolates referred by 8 medical centers...
2.
Shue Y, SEARS P, Shangle S, Walsh R, Lee C, Gorbach S, et al.
Antimicrob Agents Chemother
. 2008 Feb;
52(4):1391-5.
PMID: 18268081
Current therapies for Clostridium difficile infection (CDI) are encumbered by treatment failures and recurrences. Due to its high in vitro activity against C. difficile but low activity against the typical...
3.
Goldin B, Gorbach S
Clin Infect Dis
. 2008 Jan;
46 Suppl 2:S96-100.
PMID: 18181732
Probiotic bacteria are used to treat or prevent a broad range of human diseases, conditions, and syndromes. In addition, there are areas of medical use that have been proposed for...
4.
Snydman D, Jacobus N, McDermott L, Ruthazer R, Golan Y, Goldstein E, et al.
Antimicrob Agents Chemother
. 2007 Feb;
51(5):1649-55.
PMID: 17283189
The susceptibility trends for the species of the Bacteroides fragilis group against various antibiotics from 1997 to 2004 were determined by using data for 5,225 isolates referred by 10 medical...
5.
Wanke C, Silva M, Ganda A, Fauntleroy J, Spiegelman D, Knox T, et al.
Clin Infect Dis
. 2003 Aug;
37 Suppl 2:S81-4.
PMID: 12942378
To evaluate the contribution of acquired immune deficiency syndrome-defining conditions (ADCs) in human immunodeficiency virus (HIV)-associated wasting, we analyzed longitudinal data from 671 participants in a nutrition and HIV cohort...
6.
Forrester J, Gorbach S
Clin Infect Dis
. 2003 Aug;
37 Suppl 2:S62-8.
PMID: 12942376
Human immunodeficiency virus (HIV)-associated fat-redistribution syndrome is still a subject of controversy. There is, as yet, little agreement on the definition, etiology, and prevalence of the syndrome. Many studies have...
7.
Nichols R, Broido P, Condon R, Gorbach S, Nyhus L
Surg Infect (Larchmt)
. 2003 Feb;
1(2):133-41; discussion 143, 145-6, 147-8.
PMID: 12594901
No abstract available.
8.
Wilson I, Jacobson D, Roubenoff R, Spiegelman D, Knox T, Gorbach S
HIV Med
. 2002 Nov;
3(4):263-70.
PMID: 12444944
Context: For clinicians managing weight loss in patients with HIV, it would be useful to understand how changes in lean body mass (LBM) effect physical functioning, and whether LBM is...
9.
Gorbach S
Dig Liver Dis
. 2002 Nov;
34 Suppl 2:S2-7.
PMID: 12408431
Probiotics are "living microorganisms which upon ingestion in certain numbers exert health benefits beyond inherent general nutrition". Since 1987, when the first publication on the properties of the Lactobacillus GG...
10.
Snydman D, Jacobus N, McDermott L, Ruthazer R, Goldstein E, Finegold S, et al.
Antimicrob Agents Chemother
. 2002 Sep;
46(10):3276-9.
PMID: 12234859
The activities of BMS-284576, clinafloxacin, moxifloxacin, sitafloxacin, trovafloxacin, imipenem, cefoxitin, and clindamycin against 589 Bacteroides fragilis group isolates were determined. The activity of BMS-284576 was comparable to that of trovafloxacin....